Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 09.17.18
In explaining why mutations in the gene TP53 tend to cluster in “hot spots,” a new study lays the groundwork for ability to identify the function of any mutation in any cancer gene.Read more
Blog / 09.7.18
Postdoctoral researcher Mathias Munschauer discusses the vital, intricate functions of long non-coding RNAs and their importance in genomic research.Read more
News / 09.14.18
Looking at a brain tumor from all the angles, and what urine can teach us about heart disease risk.Read more
News / 08.27.18
Tests based on millions of common DNA variants reveal hidden disease risk; researchers work to bring them to the clinicRead more
Blog / 08.17.18
Broad fellow Jason Buenrostro’s technology-inspired journey of decoding diseases, investigating one cell at a time.Read more
News / 08.16.18
Researchers predicted these cancer-specific peptides, dubbed "retained intron" neoantigens, by computationally sifting through melanoma patients' tumor RNA.Read more
News / 08.13.18
Through this “polygenic risk scoring,” researchers can identify people at high risk for disease, even if they don’t present other warning signs; method shows potential for use in the clinicRead more
News / 08.9.18
With a detailed cell atlas of the mouse brain, scientists gain a new view into the brain's diversity
Researchers unmask unique genetic signatures of more than 560 cell populations across nine brain regions, and lay the groundwork for deeper insights into the biology of brain disorders.Read more
News / 08.8.18
Long thought to be genetically stable and identical, cancer cell lines harbor significant levels of genetic variation, which may help explain why it can be hard to reproduce findings in cell line-based research.Read more
News / 08.2.18
A common prostate cancer mutation retargets an epigenetic complex to force prostate cells down a malignant path, creating a possible therapeutic opportunity in the process.Read more
Events / 06.12.18
Save the date for our free Midsummer Nights' Science talks, which explore key advances in genomics and medicine and foster conversation between Broad scientists and the local community.Read more
Blog / 09.5.18
Broad associate member Pradeep Natarajan shares what he’s learned as head of an academic research lab and talks about his work at the intersection of genetics and cardiology, in a #WhyIScience Q&ARead more
Blog / 08.11.18
A software engineer talks about plying his problem-solving expertise in the Broad’s Data Sciences Platform, in a #WhyIScience Q&ARead more